You are here: Industry Insights > immunotherapy

News List

Roche's Alecensa topples Pfizer's Xalkori in Asian patients with ALK+ advanced lung cancer pharmafile
October 25, 2018
Following up on the reveal of data concerning its immunotherapy Tecentriq in combination with chemotherapy in the treatment of non-small cell lung cancer...
Immunotherapy success for triple-negative breast cancer europeanpharmaceuticalreview
October 23, 2018
A combination of chemotherapy and immunotherapy could soon be used in NHS hospitals for triple-negative breast cancer to extend patient survival…
Antibody combo controls HIV for months fiercebiotech
September 28, 2018
New clinical trials from Rockefeller University researchers suggest that a combination of two anti-HIV antibodies is capable of suppressing HIV for months.
Merck and Pfizer trial cancer combination with Australia’s Immutep pharmaphorum
September 27, 2018
Australian biotech Immutep has begun a clinical trial partnership with Germany’s Merck KGaA and Pfizer to develop a new cancer immunotherapy combination therapy.
Epic Sciences gathers $52M for blood tests that match cancer patients to therapies fiercebiotech
September 18, 2018
The platform aims to predict individual patients’ responses to different cancer therapies by identify cancer cells in the bloodstream using computer vision and machine learning.
Merck extends I/O lead as EU Oks Keytruda in first line lung cancer biopharmadive
September 17, 2018
Keytruda (pembrolizumab) continues to dominate in first-line NSCLC approvals, which have fueled its rapid sales growth and transformed Merck into an immunotherapy leader.
Study discovers immunotherapy could treat some aggressive prostate cancers pharmatimes
September 14, 2018
New research has discovered a subset of men with prostate cancer who have specific faults in their tumours that significantly worsen their chances...
Ultimovacs Acquires Immuneed's Immunotherapy Unit contractpharma
August 31, 2018
Ultimovacs has acquired the immunotherapy technology business of Immuneed AB for NOK 50 million.
Affimed lands big, backloaded immunotherapy deal with Genentech, sending its stock into overdrive fiercebiotech
August 29, 2018
Shares in Affimed were up more than 140% in premarket trading.
Researchers develop predictor for immunotherapy response in melanoma biospectrumasia
August 22, 2018
The predictor was developed by Noam Auslander, Ph.D., with other researchers in the Center for Cancer Research (CCR) at the National Cancer Institute (NCI)...

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page